A medical device can be designated for the De Novo pathway when it offers novel technology with a reasonable assurance of ...
As noted in Chapter 1, the committee was charged by the Food and Drug Administration (FDA) to review the 510(k) clearance process and answer two principal questions: Does the current 510(k) clearance ...
The Millipede88 aspiration catheter. [Image courtesy of Perfuze] Perfuze announced today that it received FDA 510(k) ...
Xenocor, Inc., a developer of advanced surgical visualization and minimally invasive surgery technologies, today announced the appointment of David McNally as Chief Executive Officer. McNally brings ...
Detailed price information for Kane Biotech Inc (KNE-X) from The Globe and Mail including charting and trades.
Risk-off sentiment dragged the ASX healthcare sector lower this week, headlined by Immutep’s plunge after scrapping a Phase III trial ... Read More The post Scott Power: ASX healthcare sector reels ...
The model fair value for GE HealthCare Technologies edges slightly lower from US$93.25 to US$93.05, a modest US$0.20 trim that mirrors recent shifts in published price targets. This small adjustment ...
Welcome to the NeuroOne Medical Technologies Corporation Virtual Investor Webinar. Today's call will be hosted by the company's Chief Executive Officer, Dave Rosa; and Chief Financial Officer, Ron ...
Brian Humbarger, our new Chief Commercial Officer, will provide an overview of our limited commercial launch. Before we dive into updates since our last call in November, I want to remind everyone ...
Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results